difference between semaglutide and manjaro Mounjaro vs. Ozempic: What's the Mounjaro® vs. Ozempic®: What's the

Tikkanen I, Narko K, Zeller C, et al

[] The potential kidney-protective mechanisms of GLP-1 RAs are still under investigation, and findings from the FLOW trial support the role of once-weekly subcutaneous semaglutide in slowing kidney function decline and reducing cardiovascular mortality in patients with T2D and CKD

Another potential question that clinical trials will need to assess is whether GLP-1 drugs are actually safe to take for people without obesity or diabetes, as the weight loss these drugs induce could be a damaging side effect

The Wegovy tablet is suitable for adults who want to manage their weight, including weight loss and longer-term weight maintenance, alongside a reduced-calorie diet and regular exercise